347319-95-3 Usage
Uses
Used in Medicinal Chemistry:
2-(3-Formyl-indol-1-yl)-N-furan-2-ylmethyl-acetamide is used as a scaffold for designing new drugs targeting specific biological pathways. Its unique chemical properties and structural features allow for the development of compounds with potential therapeutic effects against various diseases.
Used in Material Science:
The presence of the formyl and furan groups in 2-(3-Formyl-indol-1-yl)-N-furan-2-ylmethyl-acetamide provides it with unique chemical properties that can be exploited in material science. It may be used to develop new materials with specific properties, such as improved stability, reactivity, or selectivity.
Used in Organic Synthesis:
2-(3-Formyl-indol-1-yl)-N-furan-2-ylmethyl-acetamide can be utilized as a building block or intermediate in organic synthesis. Its unique structure and functional groups make it a valuable component in the synthesis of complex organic molecules, potentially leading to the discovery of new compounds with diverse applications.
Further research and experimentation are required to fully explore the potential properties and uses of 2-(3-Formyl-indol-1-yl)-N-furan-2-ylmethyl-acetamide in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 347319-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,7,3,1 and 9 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 347319-95:
(8*3)+(7*4)+(6*7)+(5*3)+(4*1)+(3*9)+(2*9)+(1*5)=163
163 % 10 = 3
So 347319-95-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H14N2O3/c19-11-12-9-18(15-6-2-1-5-14(12)15)10-16(20)17-8-13-4-3-7-21-13/h1-7,9,11H,8,10H2,(H,17,20)
347319-95-3Relevant academic research and scientific papers
Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis
Hartzoulakis, Basil,Rossiter, Sharon,Gill, Herpreet,O'Hara, Bernard,Steinke, Emily,Gane, Paul J.,Hurtado-Guerrero, Ramon,Leiper, James M.,Vallance, Patrick,Rust, Judith Murray,Selwood, David L.
, p. 3953 - 3956 (2008/09/16)
An efficient process for the discovery of inhibitors of DDAH enzymes, without the requirement for high throughput screening, is described. Physicochemical filtering of a 308,000-compound library according to drug likeness followed by reciprocal nearest neighbour selection produced a representative subset of 35,000 compounds. Virtual screening on a dual processor PC using FlexX, followed by biological screening, identified two hit series. Similarity searches of commercial databases and chemical re-synthesis of pure compounds resulted in SR445 as an inhibitor of Pseudomonas aeruginosa DDAH at 2 μM.
